| Net Cash Provided by (Used in) Operating Activities |
$1,601,000 |
USD |
90% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$0 |
USD |
-100% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$16,282,000 |
USD |
-46% |
Q1 2024 |
Q1 2025 |
| Common Stock, Shares Authorized |
250,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
11,978,711 |
shares |
0.02% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$1,589,000 |
USD |
-284% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$134,433,000 |
USD |
7.5% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Gross |
$134,433,000 |
USD |
4.7% |
Q4 2024 |
FY 2024 |
| Depreciation |
$0 |
USD |
-100% |
Q1 2025 |
Q1 2025 |
| Payments to Acquire Property, Plant, and Equipment |
$0 |
USD |
-100% |
Q1 2025 |
Q1 2025 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$3,227,000 |
USD |
92% |
Q3 2025 |
Q3 2025 |
| Operating Lease, Liability, Current |
$0 |
USD |
-100% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$102,145,000 |
USD |
17% |
Q4 2024 |
FY 2024 |
| Unrecognized Tax Benefits |
$0 |
USD |
|
Q3 2025 |
Q3 2025 |
| Share-based Payment Arrangement, Expense |
$435,000 |
USD |
-88% |
Q3 2025 |
Q3 2025 |
| Interest Expense |
$0 |
USD |
-100% |
Q2 2024 |
Q2 2024 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
|
Q1 2024 |
Q3 2025 |